Effects of Repeated Psilocybin Dosing in OCD

PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 20, 2023

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2027

Conditions
Obsessive-Compulsive Disorder
Interventions
DRUG

Psilocybin

"The first oral dose will be 25 mg, and the second dose will be either 25 mg or 30 mg, depending on response to first dose.~Psilocybin is a naturally occurring hallucinogenic ingredient found in some varieties of mushrooms that can be produced synthetically. It is considered to be a serotonergic psychedelic. We will use synthetically produced oral psilocybin in this study.~Other Names:~Magic Mushrooms"

Trial Locations (1)

06510

RECRUITING

Yale OCD Research Clinic (40 Temple St, 4th Floor), New Haven

All Listed Sponsors
collaborator

Steven & Alexandra Cohen Foundation

OTHER

lead

Yale University

OTHER